4- (sulfanyl-pyrimidin-4-ylmethyl) - morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy

Details for Australian Patent Application No. 2005229505 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Spooren, Will; Masciadri, Raffaello; Malherbe, Pari; Prinssen, Eric; Thomas, Andrew William

Agent Spruson & Ferguson

Pub. Number AU-B-2005229505 (Modified Examination)

PCT Pub. Number WO2005/094828

Priority 04100830.1 02.03.04 EP

Filing date 22 February 2005

Wipo publication date 13 October 2005

Acceptance publication date 15 July 2010

International Classifications

C07D 239/38 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/094828 Priority application(s): WO2005/094828

15 July 2010 Application Accepted

  Published as AU-B-2005229505 (Modified Examination)

11 November 2010 Standard Patent Sealed

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229513-Medical suturing tool

2005229497-Methods for interfering with fibrosis